Results 191 to 200 of about 866,631 (263)

Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Down syndrome regression disorder is a syndrome characterized by subacute loss of cognitive, behavioral, and functional abilities in individuals with Down syndrome. Electroencephalography abnormalities are frequently observed during evaluation, but it remains unclear whether these findings represent a dynamic marker of disease ...
Jonathan D. Santoro, Mackenzie Silverman, Maeve C. Lucas, Mariam M. Yousuf, Samuel T. Otey, Stella V. Gray, Brittany Jordan, Madeline D. Kahan, Latanya D. Agurs, Michelle Van Hirtum Das, Deborah Holder, Devin King, Eileen A. Quinn, Ryan Kammeyer, Michael S. Rafii   +14 more
wiley   +1 more source

Evaluation of a near-infrared version of TMR-PEG1k, a high-performance untargeted contrast agent for fluorescence-guided surgery, using fluorescence cryotomography. [PDF]

J Biomed Opt
Scorzo AV, Kwon CY, Strawbridge RR, Roberts DW, Paulsen KD, Davis SC.   +5 more
europepmc   +1 more source

T1 Over Squared Proton Density Ratio to Characterize Multiple Sclerosis Lesions

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Differentiating remyelinated from demyelinated lesions in MS remains challenging without histological confirmation. This study introduces the T1‐to‐PD2 ratio (TPR) imaging approach and evaluates its ability to characterize MS lesions alongside other quantitative MRI (qMRI) metrics. Methods Thirty individuals with MS (mean age: 47.5 ± 
Sarah J. Wright, Scotty G. McKay, Jean Ramos Bou, Fen Bao, Vivian B. Truong, Chenyang Li, Li Jiang, Anza B. Memon, E. Mark Haacke, Yulin Ge, Yongsheng Chen   +10 more
wiley   +1 more source

Co-Formulation of Pembrolizumab Murine Surrogate RMP1-14 with Imagent^® Ultrasound Contrast Agent Enhances Intratumoral Antibody Delivery Through a Transient Increase in Tumor Blood Perfusion. [PDF]

Pharmaceutics
Kirven IA, Penfornis P, Siddiqui MR, Butler KR, Roman RJ, Larsen CT, Howard CM, Claudio PP.   +7 more
europepmc   +1 more source

LEVERAGING CONTRAST AGENT KINETICS FOR ROBUST REFLECTANCE MODE FLUORESCENCE TOMOGRAPHY. [PDF]

Proc IEEE Int Symp Biomed Imaging
Kast M, Zayats M, Shafiee S, Zhuk S, Hesthaven JS, Joshi A.   +5 more
europepmc   +1 more source

Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell Carcinoma. [PDF]

J Nucl Med
Ricanati M, Harris U, Neumann NM, Farabi B, Kurtansky N, Rossi A, Chen CJ, Pulitzer MP, Rajadhyaksha M, Dusza S, Dhir A, Jain M.   +11 more
europepmc   +1 more source

Technical performance of dual-contrast-agent K-edge imaging with four energy thresholds on a commercial photon counting detector CT. [PDF]

Med Phys
Treb KJ, Marsh JF, Shanblatt ER, Nowak T, Dunning CAS, Fung GSK, Schmidt BT, McCollough CH, Leng S.   +8 more
europepmc   +1 more source

Contrast Agent Clearance Dynamics and Diffusion in the Mouse Brain After Ventricular Administration. [PDF]

Adv Sci (Weinh)
Decker Y, Müller A, Proulx ST.
europepmc   +1 more source

Contrast Agent

Gastroenterology, 1975
openaire   +1 more source